Monthly injection 'keeps third-biggest killer disease in the UK at bay'
Trials have shown that a monthly injection of mepolizumab significantly reduces severe symptoms of chronic obstructive pulmonary disease (COPD).
Trials have shown that a monthly injection of mepolizumab significantly reduces severe symptoms of chronic obstructive pulmonary disease (COPD).
